...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: A fair and optimistic write up on BETonMACE

Bear, like Biogen's claim for aducanumab, would higher doses of ABL in the BOM trial produced a better outcome?  

 

Koo

Share
New Message
Please login to post a reply